In a strategic accord forged in tandem with Flagship Pioneering, Novo Nordisk ha...
In response to the occurrence of two fatalities within its VX-880 diabetes drug ...
With the agreement to shell out $680 million for Harpoon Therapeutics and its on...
Bayer, the renowned pharmaceutical giant headquartered in Germany, has recently ...
Innovent, a prominent player in the Chinese pharmaceutical landscape, is gearing...
Curevo Vaccine’s bold strategic move to enter the competitive Shingles vaccine m...
AUR-101 is under clinical development by Aurigene Oncology and currently in Phas...
Subasumstat is under clinical development by Takeda Pharmaceutical and currently...
Approval for zolbetuximab was quashed after the FDA found deficiencies in the co...
The proceeds from the private placement will fund the development of Zealand’s o...
Set to lose Keytuda patent protection in 2028, MSD is shoring up its oncology po...
Biocytogen Pharmaceuticals and Radiance Biopharma have signed an exclusive optio...
BIOS Health has partnered with the City of Bakersfield, Kern County, and Kern Ve...
The EC has granted approval for Pfizer’s Talzenna (talazoparib) to treat adults ...
Johnson & Johnson (J&J) has signed a definitive agreement for the acquisition of...
HH-006 is under clinical development by Huahui Health and currently in Phase I f...